154 related articles for article (PubMed ID: 20519648)
1. Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin.
Campbell JA; Davis RS; Lilly LM; Fremont DH; French AR; Carayannopoulos LN
J Immunol; 2010 Jul; 185(1):28-32. PubMed ID: 20519648
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the cowpox virus-encoded NKG2D ligand OMCP.
Lazear E; Peterson LW; Nelson CA; Fremont DH
J Virol; 2013 Jan; 87(2):840-50. PubMed ID: 23115291
[TBL] [Abstract][Full Text] [Related]
3. Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D.
Campbell JA; Trossman DS; Yokoyama WM; Carayannopoulos LN
J Exp Med; 2007 Jun; 204(6):1311-7. PubMed ID: 17548517
[TBL] [Abstract][Full Text] [Related]
4. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.
Lenac T; Budt M; Arapovic J; Hasan M; Zimmermann A; Simic H; Krmpotic A; Messerle M; Ruzsics Z; Koszinowski UH; Hengel H; Jonjic S
J Exp Med; 2006 Aug; 203(8):1843-50. PubMed ID: 16831899
[TBL] [Abstract][Full Text] [Related]
5. Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands.
Müller S; Zocher G; Steinle A; Stehle T
PLoS Pathog; 2010 Jan; 6(1):e1000723. PubMed ID: 20090832
[TBL] [Abstract][Full Text] [Related]
6. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.
Carayannopoulos LN; Naidenko OV; Fremont DH; Yokoyama WM
J Immunol; 2002 Oct; 169(8):4079-83. PubMed ID: 12370332
[TBL] [Abstract][Full Text] [Related]
8. NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer.
Cerwenka A; Lanier LL
Tissue Antigens; 2003 May; 61(5):335-43. PubMed ID: 12753652
[TBL] [Abstract][Full Text] [Related]
9. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
[TBL] [Abstract][Full Text] [Related]
10. NKG2D/Ligand dysregulation and functional alteration of innate immunity cell populations in pediatric IBD.
La Scaleia R; Stoppacciaro A; Oliva S; Morrone S; Di Nardo G; Santoni A; Cucchiara S; Palmieri G
Inflamm Bowel Dis; 2012 Oct; 18(10):1910-22. PubMed ID: 22294522
[TBL] [Abstract][Full Text] [Related]
11. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
[TBL] [Abstract][Full Text] [Related]
12. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.
Wu J; Chalupny NJ; Manley TJ; Riddell SR; Cosman D; Spies T
J Immunol; 2003 Apr; 170(8):4196-200. PubMed ID: 12682252
[TBL] [Abstract][Full Text] [Related]
13. Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy.
Ghasemi R; Lazear E; Wang X; Arefanian S; Zheleznyak A; Carreno BM; Higashikubo R; Gelman AE; Kreisel D; Fremont DH; Krupnick AS
Nat Commun; 2016 Sep; 7():12878. PubMed ID: 27650575
[TBL] [Abstract][Full Text] [Related]
14. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus.
Yang D; Wang H; Ni B; He Y; Li J; Tang Y; Fu X; Wang Q; Xu G; Li K; Yang Z; Wu Y
Mol Immunol; 2009 Apr; 46(7):1432-42. PubMed ID: 19200602
[TBL] [Abstract][Full Text] [Related]
15. MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA.
Kim Y; Born C; Bléry M; Steinle A
Front Immunol; 2020; 11():960. PubMed ID: 32582150
[TBL] [Abstract][Full Text] [Related]
16. Innate immune recognition of double-stranded RNA triggers increased expression of NKG2D ligands after virus infection.
Esteso G; Guerra S; Valés-Gómez M; Reyburn HT
J Biol Chem; 2017 Dec; 292(50):20472-20480. PubMed ID: 28986447
[TBL] [Abstract][Full Text] [Related]
17. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
Kloss M; Decker P; Baltz KM; Baessler T; Jung G; Rammensee HG; Steinle A; Krusch M; Salih HR
J Immunol; 2008 Nov; 181(10):6711-9. PubMed ID: 18981088
[TBL] [Abstract][Full Text] [Related]
18. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions.
Sutherland CL; Chalupny NJ; Cosman D
Immunol Rev; 2001 Jun; 181():185-92. PubMed ID: 11513139
[TBL] [Abstract][Full Text] [Related]
19. Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60.
Arapović J; Lenac Rovis T; Reddy AB; Krmpotić A; Jonjić S
Mol Immunol; 2009 Nov; 47(1):114-22. PubMed ID: 19297023
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: FcR-like 6 is an MHC class II receptor.
Schreeder DM; Cannon JP; Wu J; Li R; Shakhmatov MA; Davis RS
J Immunol; 2010 Jul; 185(1):23-7. PubMed ID: 20519654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
